$MDBX Form S-1 with SEC Filing Will Bring $3.5 Million in Funding Upon Effectiveness

LOS ANGELES, CA / ACCESSWIRE / April 10, 2015 / Medbox, Inc. (MDBX), a leading provider of specialized consulting and technology solutions to the marijuana industry, today announced that the company has filed a Form S-1 with the U.S. Securities and Exchange Commission in connection with receiving approximately $3.5 million in committed funds from existing investors.

Medbox said the majority of the funds are to be received upon the SEC declaring the Form S-1 effective and will be used principally for working capital and general corporate purposes.

About Medbox, Inc.

Medbox is a leading dispensary and cultivation infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Medbox utilizes its expertise to work with investors and entrepreneurs who seek to enter the cannabis sector, providing them with a high quality turn-key solution, consisting of licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide. For more information about the company, visit www.medbox.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements, including, but not limited to, the SEC declaring the Form S-I effective and receiving a majority of the $3.5 million in funds therefrom, are based on current beliefs and expectations and are inherently subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the company’s control. In addition, certain forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties also include, but are not limited to, regulatory developments in the industry, as well as political and economic conditions present within the industry. The company does not assume any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made, unless required by law.

For more information, contact:

Janet Simmons
PondelWilkinson Inc.
310-279-5980
pwinvestor@pondel.com

SOURCE: Medbox, Inc.